1. T1 glottic laryngeal cancer:the role of routine follow-up visits in detecting local recurrence
- Author
-
Pakkanen, P. (Pihla), Ilmarinen, T. (Taru), Halme, E. (Elina), Irjala, H. (Heikki), Koivunen, P. (Petri), Pukkila, M. (Matti), Ventelä, S. (Sami), Hagström, J. (Jaana), Aaltonen, L.-M. (Leena-Maija), Pakkanen, P. (Pihla), Ilmarinen, T. (Taru), Halme, E. (Elina), Irjala, H. (Heikki), Koivunen, P. (Petri), Pukkila, M. (Matti), Ventelä, S. (Sami), Hagström, J. (Jaana), and Aaltonen, L.-M. (Leena-Maija)
- Abstract
Purpose: We assessed the treatment outcome and the benefits of routine follow-up visits in T1 glottic laryngeal squamous cell carcinoma (LSCC). Methods: Medical records of patients diagnosed with stage T1 glottic LSCC (N = 303) in five Finnish university hospitals between 2003 and 2015 were reviewed. Moreover, data from the Finnish Cancer Registry and the Population Register Center were collected. Results: Of all 38 recurrences, 26 (68%) were detected during a routine follow-up visit, and over half (21 of 38, 55%) presented without new symptoms. Primary treatment method (surgery vs. radiotherapy) was not connected with 5-year disease-specific survival (DSS) or laryngeal preservation rate. Conclusion: The majority of recurrences were detected on a routine follow-up visit, and local recurrences often presented without new symptoms. Routine post-treatment follow-up of T1 glottic LSCC seems beneficial. Trial registration: Trial registration number and date of registration HUS/356/2017 11.12.2017.
- Published
- 2021